Redguard, D. A. (2020). SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:332245
Redguard, Daren Anthony. "SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients." Master's thesis, University of Zagreb, School of Medicine, 2020. https://urn.nsk.hr/urn:nbn:hr:105:332245
Redguard, Daren Anthony. "SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients." Master's thesis, University of Zagreb, School of Medicine, 2020. https://urn.nsk.hr/urn:nbn:hr:105:332245
Redguard, D. A. (2020). 'SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients', Master's thesis, University of Zagreb, School of Medicine, accessed 25 August 2024, https://urn.nsk.hr/urn:nbn:hr:105:332245
Redguard DA. SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2020 [cited 2024 August 25] Available at: https://urn.nsk.hr/urn:nbn:hr:105:332245
D. A. Redguard, "SGLT-2 inhibitors for the treatment of type-2 diabetes in heart failure patients", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2020. Available at: https://urn.nsk.hr/urn:nbn:hr:105:332245